- Home
- API vs HUMA Comparison
API vs HUMA Comparison
Compare API & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- HUMA
- Stock Information
- Founded
- API 2013
- HUMA 2004
- Country
- API United States
- HUMA United States
- Employees
- API N/A
- HUMA N/A
- Industry
- API Computer Software: Prepackaged Software
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- API Technology
- HUMA Health Care
- Exchange
- API Nasdaq
- HUMA Nasdaq
- Market Cap
- API 518.0M
- HUMA 427.2M
- IPO Year
- API 2020
- HUMA N/A
- Fundamental
- Price
- API $4.04
- HUMA $1.49
- Analyst Decision
- API Strong Buy
- HUMA Strong Buy
- Analyst Count
- API 1
- HUMA 6
- Target Price
- API $6.00
- HUMA $14.60
- AVG Volume (30 Days)
- API 609.0K
- HUMA 5.2M
- Earning Date
- API 05-21-2025
- HUMA 03-28-2025
- Dividend Yield
- API N/A
- HUMA N/A
- EPS Growth
- API N/A
- HUMA N/A
- EPS
- API N/A
- HUMA N/A
- Revenue
- API $133,256,000.00
- HUMA N/A
- Revenue This Year
- API $6.89
- HUMA N/A
- Revenue Next Year
- API $10.96
- HUMA $1,217.58
- P/E Ratio
- API N/A
- HUMA N/A
- Revenue Growth
- API N/A
- HUMA N/A
- 52 Week Low
- API $1.65
- HUMA $1.31
- 52 Week High
- API $6.99
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- API 33.33
- HUMA 22.36
- Support Level
- API $4.52
- HUMA $1.96
- Resistance Level
- API $4.84
- HUMA $3.36
- Average True Range (ATR)
- API 0.29
- HUMA 0.26
- MACD
- API -0.12
- HUMA -0.13
- Stochastic Oscillator
- API 11.64
- HUMA 8.74
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.